Clinical similarity of the biosimilar ABP 501 compared with adalimumab after single transition: long-term results from a randomized controlled, double-blind, 52-week, phase III trial in patients with moderate-to-severe plaque psoriasis
2017 ◽
Vol 177
(6)
◽
pp. 1562-1574
◽
Keyword(s):
Keyword(s):
2017 ◽
Vol 76
(6)
◽
pp. 1093-1102
◽
Keyword(s):
2004 ◽
Vol 59
(4)
◽
pp. 943-951
◽
Keyword(s):
Keyword(s):
Keyword(s):